Clonidine in Child and Adolescent Psychiatry

Journal of Child and Adolescent Psychopharmacology

Volumn 1, Issue 1, 1990, Pages 87-102

  Hunt, Robert D ^a   Capper, Lisa ^b   O’connell, Patricia ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010117149     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.1990.1.87     Document Type: Article

References (50)

1. Abuzzahab FS: Clonidine HCl in Gilles de la Tourette syndrome. First International Gilles de la Tourette Syndrome Symposium, 1981; 17(Abstr)
2. Amsterdam JD, Maislin G, Skolnick B, Berwish N, Winokur A: Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers. Biol Psychiatry 1989; 26:265–278
3. Angrist B, Smith M, Adler L, Peselow E, Reitano J, Rotrosen J: Preliminary studies of clonidine in psychotic patients. J Neural Transm 1988;71:115–121
4. Antelman SM, Caggiula AR: Norepinephrine-dopamine interactions and behavior. Science 1977; 195:646–653
5. Borison RL, Ang L, Hamilton WJ, Diamond BI, David JM: Treatment approaches in Gilles de la Tourette syndrome. Brain Res Bull 1983; 11:205–208
6. Bruun RD: Gilles de la Tourette syndrome. An overview of clinical experience. J Am Acad Child Psychiatry 1984; 23:126–133
7. Bunney BS, DeRiemer SA: Effects of clonidine on nigral dopamine cell activity: Possible mediation by noradrenergic regulation of serotonergic raphe system. In: A.J. Friedhoff & T.N. Chase (Eds.), Gilles de la Tourette Syndrome. New York: Raven, 1982
8. Caine ED, McBride MC, Chivertón P, Bamford KA, Rediess S, Shiao J: Tourette's syndrome in Monroe County school children. Neurology 1988; 38:472–475
9. Chen SW, Vidt DG: Patient acceptance of transdermal clonidine: A retrospective review of 25 patients. Cleve Clin J Med 1989; 56:21–26
10. Cohen DJ, Bruun RD, Leckman JF (Eds.): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York: John Wiley & Sons, 1988
11. Cohen DJ, Detlor J, Young JG, Shaywitz BA: Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980;37:1350–1354
12. Dawson PM, Vander-Zanden JA, Werkman SL, Washington RL, Tyma TA: Cardiac dysrhythmia with the use of clonidine in explosive disorder. DICP 1989; 23:465–466
13. Erenberg G: Pharmacologie therapy of tics in childhood. Pediatr Ann 1988; 17:395–404
14. Friedman MJ: Toward rational pharmacotherapy for posttraumatic stress disorder: An interim report. Am J Psychiatry 1988; 145:281–285
15. Fulton WA, Shady GA, Champion LM: An evaluation of Tourette syndrome and medication use in Canada. Neurosci Biobehav Rev 1988; 12:251–254
16. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Sandberg D, Fyer M, Hollander E, Papp L, Goetz D, Klein DF: Effects of clonidine on alprazolam discontinuation in panic patients: A pilot study. J Clin Psychopharmacol 1988; 8:270–274
17. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM: Clonidine and Gilles de la Tourette syndrome: Double-blind study using objective rating methods. Ann Neurol 1987; 21:307–310
18. Goetz CG, Shannon KM, Carroll VS, Tanner CM, Weingarten R: The autonomie nervous system in Gilles de la Tourette's syndrome. Mov Disord 1987; 2:99–102
19. Golden GS: Tourette syndrome: Recent advances. Pediatr Neurol 1986; 2:189–192
20. Huk SG: Transient exacerbation of tics in treatment of Tourette's syndrome with clonidine. J Am Acad Child Adolesc Psychiatry 1989;28:583–586
21. Hunt RD: Treatment effects of oral and transdermal clonidine in relation to methylphenidate—An open pilot study in ADDH. Psychopharmacol Bull 1987; 23:111–114
22. Hunt RD: Treatment of ADHD with clonidine: Guidelines for physicians. Psychiatric Times, September 1988
23. Hunt RD, Clapper L, Ebert MH: Clonidine and methylphenidate: Combined use in treatment of selected ADHD children. Presentation: Annual Meeting, American Academy of Child and Adolescent Psychiatry, New York, October 1989
24. Hunt RD, Cohen DJ, Anderson G, Minderaa R: Noradrenergic Mechanisms in ADDH. In Bloomingdale, LM (Ed.), Attention Deficit Disorder: New Research in Attention, Treatment, and Psychopharmacology. New York: Pergamon Press, 1988
25. Hunt RD, Minderaa RB, Cohen DJ: Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-controlled crossover study. J Am Acad Child Psychiatry 1985; 24:617–629
26. Hunt RD, Minderaa RB, Cohen DJ: The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: A comparison with placebo. Psychopharmacol Bull 1986; 22:229–236
27. Jankovic J, Rohaidy H: Motor, behavioral and pharmacologie findings in Tourette's syndrome. Can J Neurol Sci 1987; 14 (3 Suppl):541–546
28. Jouvent R, Lecrubier Y, Hardy MC, Widlocher D: Clonidine and neuroleptic-resistant mania [letter]. Br J Psychiatry 1988; 152:293–294
29. Kerbeshian J, Burd L: A clinical pharmacological approach to treating Tourette syndrome in children and adolescents. Neurosci Biobehav Rev 1988; 12:241–245
30. Kinzie JD, Leung P: Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 1989; 177:546–550
31. Kontaxakis V, Markianos M, Markidis M, Stefanis C: Clonidine in the treatment of mixed bipolar disorder. Acta Psychiatr Scand 1989; 79:108–110
32. Leckman JF, Cohen DJ: Recent advances in Gilles de la Tourette syndrome: Implications for clinical practice and future research. Psychiatr Dev 1983; 1:301–316
33. Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherik DF, Hoder EL: Whole blood serotonin and tryptophan levels in Tourette's disorder: Effects of acute and chronic clonidine treatment. Life Sci 1984; 35:2497–2503
34. Leckman JF, Detlor J, Harcherik DF, Ort S, Shaywitz BA, Cohen DJ: Short and long term treatment of Tourette's syndrome with clonidine: A clinical perspective. Neurology 1985; 5:343–351
35. Leckman JF, Ort S, Caruso KA, Anderson GM, Riddle MA, Cohen DJ: Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine: Behavioral, cardiovascular, and neurochemical effects. Arch Gen Psychiatry 1986; 43:1168–1176
36. Leckman JF, Walkup JT, Cohen DJ: Clonidine treatment of Tourette's syndrome. In Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. DJ Cohen, RD Bruun, and JF Leckman (Eds.), New York: John Wiley & Sons, 1988
37. Lee DD, DeQuattro V, Davison GC, Kimura S, Barndt R, Sullivan P: Noradrenergic hyperactivity in primary hypertension: Central and peripheral markers of both behavioral pathogenesis and efficacy of sympatholytic and relaxation therapy. Clin Exp Hypertens A 1988; 10 (Suppl 1):225–234
38. Lowenthal DT, Matzek KM, MacGregor TR: Clinical pharmacokinetics of clonidine. Clin Pharmacokinet 1988; 14:287–310
39. Manheim P, Paalzow L, Hokfelt B: Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension. Clin Pharmacol Ther 1982;31:445–451
40. Martin PR, Ebert MH, Gordon EK, Linnoila M, Kopin IJ: Effects of clonidine on central and peripheral catecholamine metabolism. Clin Pharmacol Therapeutic 1984; 35:322–327
41. Max JE, Rasmussen SA: Clonidine in the treatment of Tourette's syndrome exacerbation due to haloperidol withdrawal. J Nerv Ment Dis 1986; 174:243–246
42. Mesulam MM, Petersen RC: Treatment of Gilles de la Tourette's syndrome: Eight-year, practice-based experience in a predominantly adult population. Neurology 1987; 37:1828–1833
43. Nutt DJ: Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989; 46:165–169
44. Regeur L, Pakkenberg B, Fog R, Pakkenberg H: Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 1986; 49:791–795
45. Shapiro AK, Shapiro E, Eisenkraft GJ: Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Arch Gen Psychiatry 1983; 40:1235–1248
46. Silverstein F, Smith CB, Johnston MV: Effect of clonidine on platelet alpha 2-adrenoreceptors and plasma norepinephrine of children with Tourette syndrome. Dev Med Child Neurol 1985; 27:793–799
47. Singer HS, Gammon K, Quaskey S: Haloperidol, fluphenazine and clonidine in Tourette syndrome: Controversies in treatment. Pediatric Neurol Sci 1986; 12:71–74
48. Troung DD, Bressman S, Shale H, Fahn S: Clonazepam, haloperidol, and clonidine in tic disorders. South Med J 1988; 81:1103–1105
49. Uhde TW, Stein MB, Vittone BJ, Siever LJ, Boulenger JP, Klein E, Mellman TA: Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 1989; 46:170–177
50. van Kammen DP, Peters JL, van Kämmen WB, Rosen J, Yao JK, McAdam D, Linnoila M: Clonidine treatment of schizophrenia: Can we predict treatment response? Psychiatry Res 1989; 27:297–311